Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Ghavami, Saeid  [Clear All Filters]
2023
Davodabadi F, Sajjadi SFatemeh, Sarhadi M, Mirghasemi S, Hezaveh MNadali, Khosravi S, Andani MKamali, Cordani M, Basiri M, Ghavami S. Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery. Eur J Pharmacol. 2023:176013.
Siapoush S, Rezaei R, Alavifard H, Hatami B, Zali MReza, Vosough M, Lorzadeh S, Łos MJ, Baghaei K, Ghavami S. Therapeutic implications of targeting autophagy and TGF-β crosstalk for the treatment of liver fibrosis. Life Sci. 2023:121894.
2020
Mazhari S, Gitiara A, Baghaei K, Hatami B, Rad REslami, Asadirad A, Joharchi K, Tokhanbigli S, Hashemi SMahmoud, Łos MJ, et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis. Eur J Pharmacol. 2020:173263.
2019
Sharifzad F, Ghavami S, Mardpour S, Mollapour M, Azizi Z, Taghikhani A, Łos MJ, Verdi J, Fakharian E, Ebrahimi M, et al. Glioblastoma cancer stem cell biology: Potential theranostic targets. Drug Resist Updat. 2019;42:35-45.
2016
Likus W, Siemianowicz K, Bieńk K, Pakuła M, Pathak H, Dutta C, Wang Q, Shojaei S, Assaraf YG, Ghavami S, et al. Could drugs inhibiting the mevalonate pathway also target cancer stem cells?. Drug Resist Updat. 2016;25:13-25.
2014
Hombach-Klonisch S, Natarajan S, Thanasupawat T, Medapati M, Pathak A, Ghavami S, Klonisch T. Mechanisms of Therapeutic Resistance in Cancer (Stem) Cells with Emphasis on Thyroid Cancer Cells. Front Endocrinol (Lausanne). 2014;5:37.